MXCT
HealthcareMaxCyte, Inc.
$0.83-0.01 (-1.03%)
Prev Close
$0.83
Open
$0.84
High
$0.87
Low
$0.81
Volume
934.7K
Market Cap
$82.8M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at MaxCyte, Inc. (MXCT) has been dominated by buying, with 3 insider purchases totaling $304.6K and 2 insider sales totaling $23.5K. The most recent insider transaction was by Brooke William W (Director), who purchased $64.5K worth of shares on Aug 13, 2025. MaxCyte, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $82.8M.
Buys (12M)
3
$304.6K
Sells (12M)
2
$23.5K
Net Activity
Net Buyer
$281.1K
Active Insiders
5
last 12 mo
MXCT Price Chart
MXCT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 13, 2025↗ | Brooke William W | Director | Buy | 50,000 | $1.29 | $64.5K | 0 |
| Aug 13, 2025↗ | Erck Stanley C | Director | Buy | 100,000 | $1.37 | $137.2K | 0 |
| Aug 13, 2025↗ | Masoud Maher | President and CEO | Buy | 75,000 | $1.37 | $102.9K | 0 |
| Jun 25, 2025↗ | Hemrajani Rekha | Director | Sell | 10,684 | $2.09 | $22.4K | 0 |
| Mar 18, 2025↗ | Sandoval David I. | GENERAL COUNSEL | Sell | 353 | $3.18 | $1.1K | 0 |
| Jan 29, 2025↗ | Johnston John Joseph | Sell | 3,000 | $4.65 | $13.9K | 141,950 | |
| Jan 14, 2025↗ | Sandoval David I. | GENERAL COUNSEL | Sell | 4,466 | $4.54 | $20.3K | 41,447 |
| Dec 30, 2024↗ | Johnston John Joseph | Sell | 3,000 | $4.01 | $12.0K | 141,950 | |
| Dec 10, 2024↗ | Johnston John Joseph | Sell | 3,000 | $3.78 | $11.3K | 141,950 | |
| Nov 5, 2024↗ | Erck Stanley C | Sell | 47,689 | $3.72 | $177.4K | 269,118 | |
| Oct 30, 2024↗ | Johnston John Joseph | Sell | 3,000 | $3.72 | $11.2K | 141,950 | |
| Oct 2, 2024↗ | Erck Stanley C | Sell | 47,689 | $3.75 | $178.8K | 269,118 | |
| Sep 30, 2024↗ | Johnston John Joseph | Sell | 3,000 | $3.82 | $11.5K | 141,950 | |
| Sep 5, 2024↗ | Erck Stanley C | Sell | 47,689 | $4.02 | $191.7K | 269,118 | |
| Aug 28, 2024↗ | Johnston John Joseph | Sell | 3,000 | $4.28 | $12.8K | 141,950 | |
| Aug 5, 2024↗ | Ross Thomas M. | EVP, GLOBAL SALES | Sell | 33,333 | $4.44 | $148.1K | 25,000 |
| Jul 30, 2024↗ | Johnston John Joseph | Sell | 3,000 | $4.75 | $14.2K | 141,950 | |
| Jul 10, 2024↗ | Ross Thomas M. | EVP, GLOBAL SALES | Sell | 33,333 | $4.03 | $134.4K | 25,000 |
| Jul 1, 2024↗ | Johnston John Joseph | Sell | 10,000 | $3.99 | $39.9K | 141,950 | |
| Jun 24, 2024↗ | Ross Thomas M. | EVP, GLOBAL SALES | Sell | 33,333 | $4.09 | $136.5K | 25,000 |
| Jun 10, 2024↗ | Masoud Maher | President and CEO | Buy | 100,000 | $4.89 | $489.1K | 100,000 |
| Mar 28, 2024↗ | Johnston John Joseph | Sell | 5,000 | $4.41 | $22.0K | 120,583 | |
| Feb 28, 2024↗ | Johnston John Joseph | Sell | 5,000 | $4.60 | $23.0K | 120,583 | |
| Jan 30, 2024↗ | Johnston John Joseph | Sell | 5,000 | $5.12 | $25.6K | 120,583 | |
| Dec 28, 2023↗ | Johnston John Joseph | Director | Sell | 5,000 | $4.53 | $22.6K | 120,583 |
| Dec 6, 2023↗ | Doerfler Douglas | President and CEO | Sell | 124,450 | $5.14 | $639.4K | 333,197 |
| Dec 1, 2023↗ | Doerfler Douglas | President and CEO | Sell | 25,550 | $5.00 | $127.8K | 333,197 |
| Nov 29, 2023↗ | Johnston John Joseph | Director | Sell | 5,000 | $4.59 | $22.9K | 120,583 |
| Nov 16, 2023↗ | Johnston John Joseph | Director | Sell | 10,000 | $3.71 | $37.1K | 120,583 |
| Aug 30, 2023↗ | Johnston John Joseph | Director | Sell | 5,000 | $3.70 | $18.5K | 120,583 |
| Jul 28, 2023↗ | Johnston John Joseph | Director | Sell | 5,000 | $4.75 | $23.8K | 120,583 |
| Jul 12, 2023↗ | Doerfler Douglas | President and CEO | Sell | 30,000 | $5.03 | $150.9K | 333,197 |
| Jun 28, 2023↗ | Johnston John Joseph | Director | Sell | 15,000 | $4.44 | $66.6K | 120,583 |
| Jun 15, 2023↗ | Doerfler Douglas | President and CEO | Sell | 43,851 | $5.04 | $220.9K | 333,197 |
| May 5, 2023↗ | Doerfler Douglas | President and CEO | Sell | 16,149 | $5.02 | $81.1K | 333,197 |
| Apr 12, 2023↗ | Doerfler Douglas | President and CEO | Sell | 15,000 | $5.00 | $75.0K | 333,197 |
| Apr 12, 2023↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 14,134 | $5.00 | $70.7K | 0 |
| Apr 7, 2023↗ | Doerfler Douglas | President and CEO | Sell | 34,823 | $5.02 | $175.0K | 333,197 |
| Apr 7, 2023↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 34,160 | $5.02 | $171.6K | 0 |
| Apr 4, 2023↗ | Doerfler Douglas | President and CEO | Sell | 10,177 | $5.02 | $51.1K | 333,197 |
| Apr 4, 2023↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 9,973 | $5.02 | $50.1K | 0 |
| Mar 30, 2023↗ | DOUGLAS RICHARD | Director | Buy | 80,000 | $4.32 | $345.5K | 100,000 |
| Feb 3, 2023↗ | Doerfler Douglas | President and CEO | Sell | 30,000 | $5.72 | $171.6K | 333,197 |
| Feb 3, 2023↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 29,133 | $5.72 | $166.5K | 0 |
| Jan 5, 2023↗ | Doerfler Douglas | President and CEO | Sell | 30,000 | $5.08 | $152.4K | 333,197 |
| Jan 5, 2023↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 29,133 | $5.08 | $148.1K | 0 |
| Dec 6, 2022↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 29,133 | $5.81 | $169.3K | 0 |
| Nov 3, 2022↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 29,133 | $6.92 | $201.7K | 0 |
| Oct 12, 2022↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 29,133 | $6.46 | $188.2K | 0 |
| Oct 5, 2022↗ | Casdin Partners Master Fund, L.P. | 10% Owner | Sell | 735,786 | $6.15 | $4.53M | 10,000,000 |
Showing 1–50 of 51
1 / 2
MXCT Insider Buying Activity
The following table shows recent insider purchases of MaxCyte, Inc. (MXCT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 13, 2025↗ | Brooke William W | Director | Buy | 50,000 | $1.29 | $64.5K | 0 |
| Aug 13, 2025↗ | Erck Stanley C | Director | Buy | 100,000 | $1.37 | $137.2K | 0 |
| Aug 13, 2025↗ | Masoud Maher | President and CEO | Buy | 75,000 | $1.37 | $102.9K | 0 |
| Jun 10, 2024↗ | Masoud Maher | President and CEO | Buy | 100,000 | $4.89 | $489.1K | 100,000 |
| Mar 30, 2023↗ | DOUGLAS RICHARD | Director | Buy | 80,000 | $4.32 | $345.5K | 100,000 |
MXCT Insider Selling Activity
The following table shows recent insider sales of MaxCyte, Inc. (MXCT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025↗ | Hemrajani Rekha | Director | Sell | 10,684 | $2.09 | $22.4K | 0 |
| Mar 18, 2025↗ | Sandoval David I. | GENERAL COUNSEL | Sell | 353 | $3.18 | $1.1K | 0 |
| Jan 29, 2025↗ | Johnston John Joseph | Sell | 3,000 | $4.65 | $13.9K | 141,950 | |
| Jan 14, 2025↗ | Sandoval David I. | GENERAL COUNSEL | Sell | 4,466 | $4.54 | $20.3K | 41,447 |
| Dec 30, 2024↗ | Johnston John Joseph | Sell | 3,000 | $4.01 | $12.0K | 141,950 | |
| Dec 10, 2024↗ | Johnston John Joseph | Sell | 3,000 | $3.78 | $11.3K | 141,950 | |
| Nov 5, 2024↗ | Erck Stanley C | Sell | 47,689 | $3.72 | $177.4K | 269,118 | |
| Oct 30, 2024↗ | Johnston John Joseph | Sell | 3,000 | $3.72 | $11.2K | 141,950 | |
| Oct 2, 2024↗ | Erck Stanley C | Sell | 47,689 | $3.75 | $178.8K | 269,118 | |
| Sep 30, 2024↗ | Johnston John Joseph | Sell | 3,000 | $3.82 | $11.5K | 141,950 | |
| Sep 5, 2024↗ | Erck Stanley C | Sell | 47,689 | $4.02 | $191.7K | 269,118 | |
| Aug 28, 2024↗ | Johnston John Joseph | Sell | 3,000 | $4.28 | $12.8K | 141,950 | |
| Aug 5, 2024↗ | Ross Thomas M. | EVP, GLOBAL SALES | Sell | 33,333 | $4.44 | $148.1K | 25,000 |
| Jul 30, 2024↗ | Johnston John Joseph | Sell | 3,000 | $4.75 | $14.2K | 141,950 | |
| Jul 10, 2024↗ | Ross Thomas M. | EVP, GLOBAL SALES | Sell | 33,333 | $4.03 | $134.4K | 25,000 |
| Jul 1, 2024↗ | Johnston John Joseph | Sell | 10,000 | $3.99 | $39.9K | 141,950 | |
| Jun 24, 2024↗ | Ross Thomas M. | EVP, GLOBAL SALES | Sell | 33,333 | $4.09 | $136.5K | 25,000 |
| Mar 28, 2024↗ | Johnston John Joseph | Sell | 5,000 | $4.41 | $22.0K | 120,583 | |
| Feb 28, 2024↗ | Johnston John Joseph | Sell | 5,000 | $4.60 | $23.0K | 120,583 | |
| Jan 30, 2024↗ | Johnston John Joseph | Sell | 5,000 | $5.12 | $25.6K | 120,583 | |
| Dec 28, 2023↗ | Johnston John Joseph | Director | Sell | 5,000 | $4.53 | $22.6K | 120,583 |
| Dec 6, 2023↗ | Doerfler Douglas | President and CEO | Sell | 124,450 | $5.14 | $639.4K | 333,197 |
| Dec 1, 2023↗ | Doerfler Douglas | President and CEO | Sell | 25,550 | $5.00 | $127.8K | 333,197 |
| Nov 29, 2023↗ | Johnston John Joseph | Director | Sell | 5,000 | $4.59 | $22.9K | 120,583 |
| Nov 16, 2023↗ | Johnston John Joseph | Director | Sell | 10,000 | $3.71 | $37.1K | 120,583 |
| Aug 30, 2023↗ | Johnston John Joseph | Director | Sell | 5,000 | $3.70 | $18.5K | 120,583 |
| Jul 28, 2023↗ | Johnston John Joseph | Director | Sell | 5,000 | $4.75 | $23.8K | 120,583 |
| Jul 12, 2023↗ | Doerfler Douglas | President and CEO | Sell | 30,000 | $5.03 | $150.9K | 333,197 |
| Jun 28, 2023↗ | Johnston John Joseph | Director | Sell | 15,000 | $4.44 | $66.6K | 120,583 |
| Jun 15, 2023↗ | Doerfler Douglas | President and CEO | Sell | 43,851 | $5.04 | $220.9K | 333,197 |
| May 5, 2023↗ | Doerfler Douglas | President and CEO | Sell | 16,149 | $5.02 | $81.1K | 333,197 |
| Apr 12, 2023↗ | Doerfler Douglas | President and CEO | Sell | 15,000 | $5.00 | $75.0K | 333,197 |
| Apr 12, 2023↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 14,134 | $5.00 | $70.7K | 0 |
| Apr 7, 2023↗ | Doerfler Douglas | President and CEO | Sell | 34,823 | $5.02 | $175.0K | 333,197 |
| Apr 7, 2023↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 34,160 | $5.02 | $171.6K | 0 |
| Apr 4, 2023↗ | Doerfler Douglas | President and CEO | Sell | 10,177 | $5.02 | $51.1K | 333,197 |
| Apr 4, 2023↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 9,973 | $5.02 | $50.1K | 0 |
| Feb 3, 2023↗ | Doerfler Douglas | President and CEO | Sell | 30,000 | $5.72 | $171.6K | 333,197 |
| Feb 3, 2023↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 29,133 | $5.72 | $166.5K | 0 |
| Jan 5, 2023↗ | Doerfler Douglas | President and CEO | Sell | 30,000 | $5.08 | $152.4K | 333,197 |
| Jan 5, 2023↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 29,133 | $5.08 | $148.1K | 0 |
| Dec 6, 2022↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 29,133 | $5.81 | $169.3K | 0 |
| Nov 3, 2022↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 29,133 | $6.92 | $201.7K | 0 |
| Oct 12, 2022↗ | Ross Thomas M. | EVP, Global Sales & Marketing | Sell | 29,133 | $6.46 | $188.2K | 0 |
| Oct 5, 2022↗ | Casdin Partners Master Fund, L.P. | 10% Owner | Sell | 735,786 | $6.15 | $4.53M | 10,000,000 |
MXCT Insiders
Similar Stocks to MXCT
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
SYK
Stryker Corporation
$336.96-0.07%
$129.05B
BSX
Boston Scientific Corporation
$68.91+0.51%
$101.72B
EW
Edwards Lifesciences Corporation
$81.76-3.37%
$49.14B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$273.67-3.21%
$47.35B
DXCM
DexCom, Inc.
$64.51-1.15%
$25.45B
ZBH
Zimmer Biomet Holdings, Inc.
$93.20+0.77%
$18.47B
PODD
Insulet Corporation
$219.84-6.34%
$15.48B